World Wires · story 12543 · unverified · 1 source(s)

Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities

WATERTOWN, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a biotechnology company pioneering a new class of medicines

Open in the desk

Coverage

• Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities GlobeNewswire: public companies · tier D · clear net · 2026-10-01 11:00 UTC

What this site indexes